Skip to Content
You are currently on the new version of our website. Access the old version .

2,066 Results Found

  • Article
  • Open Access
12 Citations
6,966 Views
18 Pages

Triple-Frequency Code-Phase Combination Determination: A Comparison with the Hatch-Melbourne-Wübbena Combination Using BDS Signals

  • Chenlong Deng,
  • Weiming Tang,
  • Jianhui Cui,
  • Mingxing Shen and ,
  • Zongnan Li,
  • Xuan Zou and
  • Yongfeng Zhang
  • + 2 authors+ 0 author

24 February 2018

Considering the influence of the ionosphere, troposphere, and other systematic errors on double-differenced ambiguity resolution (AR), we present an optimal triple-frequency code-phase combination determination method driven by both the model and the...

(This article belongs to the Special Issue Multi-Constellation Global Navigation Satellite Systems: Methods and Applications)
  • Article
  • Open Access
31 Citations
6,745 Views
15 Pages

Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells

  • Malgorzata Bajor,
  • Agnieszka Graczyk-Jarzynka,
  • Katsiaryna Marhelava,
  • Malgorzata Kurkowiak and ,
  • Arman Rahman,
  • Claudia Aura,
  • Niamh Russell,
  • Agata O. Zych,
  • Malgorzata Firczuk and
  • Radoslaw Zagozdzon
  • + 7 authors+ 2 authors

Triple-negative breast cancer (TNBC) is an aggressive form of mammary malignancy currently without satisfactory systemic treatment options. Agents generating reactive oxygen species (ROS), such as ascorbate (Asc) and menadione (Men), especially appli...

(This article belongs to the Special Issue Peroxiredoxin)
  • Article
  • Open Access
98 Views
20 Pages

Impact of Combination Drugs on the Transcriptome Profiles of Triple-Negative Breast Cancer Cells

  • Tusha Sharma,
  • Rishika Pamanji,
  • Suneetha Yeguvapalli,
  • Fatima Merchant and ,
  • Dinler Amaral Antunes,
  • Meghana Trivedi and
  • Kumaraswamy Naidu Chitrala
  • + 2 authors+ 0 author

Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer and poses significant treatment challenges due to fewer available options. Creating highly specific and precise anticancer therapies continues to be a significant chall...

(This article belongs to the Collection Feature Papers in Current Issues in Molecular Biology)
  • Review
  • Open Access
14 Citations
5,449 Views
24 Pages

6 December 2021

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and is known to be associated with a poor prognosis and limited therapeutic options. Poly (ADP-ribose) polymerase inhibitors (PARPi) are targeted therapeutics that...

(This article belongs to the Special Issue Potential Molecular Targets and Therapeutics in Triple-Negative Breast Cancer)
  • Article
  • Open Access
3 Citations
768 Views
9 Pages

Impact of Health Technology Assessment on Prescribing Patterns of Inhaled Fixed-Dose Combination Triple Therapy in Chronic Obstructive Pulmonary Disease

  • Jennifer Cook,
  • Chloe Bloom,
  • Jen Lewis,
  • Zoe Marjenberg and ,
  • Jaime Hernando Platz and
  • Sue Langham
  • + 1 author+ 0 author

Background: Evidence suggests that triple therapy for patients with chronic obstructive pulmonary disease (COPD) is being used in a broader range of patients than recommended by guidelines, which may have health and cost implications. Objective: To...

  • Article
  • Open Access
7 Citations
3,882 Views
19 Pages

Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines

  • Fu Hou Wong,
  • Vijayaraj Kumar Palanirajan,
  • Edmond Siah Chye Ng,
  • Chung Keat Tan and ,
  • Eugenie Sin Sing Tan and
  • Farahnaz Amini
  • + 1 author+ 0 author

29 August 2022

Monotherapy for triple−negative breast cancer (TNBC) is often ineffective. This study aimed to investigate the effect of calcitriol and talazoparib combination on cell proliferation, migration, apoptosis and cell cycle in TNBC cell lines. Monot...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
18 Citations
6,241 Views
9 Pages

17 December 2021

The aim of this study was to comparatively evaluate clinical, laboratory and hemodynamic effects on the long term of different triple combination antihypertensive medications in a well-characterized Italian cohort. We considered the data of a subset...

(This article belongs to the Collection Hypertension: Etiology, Risk Factors, Associated Symptoms and Treatment)
  • Article
  • Open Access
1 Citations
3,304 Views
11 Pages

14 May 2022

Using the navigation signal transmitted by GNSS (global navigation satellite system), satellites for tide level monitoring comprise one of the important research fields of GNSS marine remote sensing. Regarding the problem that GNSS-MR (multipath refl...

(This article belongs to the Topic Multi-Sensor Integrated Navigation Systems)
  • Article
  • Open Access
12 Citations
4,000 Views
22 Pages

Application of Novel Transcription Factor Machine Learning Model and Targeted Drug Combination Therapy Strategy in Triple Negative Breast Cancer

  • Jianyu Pang,
  • Huimin Li,
  • Xiaoling Zhang,
  • Zhengwei Luo and ,
  • Yongzhi Chen,
  • Haijie Zhao,
  • Handong Lv,
  • Hongan Zheng,
  • Zhiqian Fu and
  • Miaomiao Sheng
  • + 6 authors+ 1 author

31 August 2023

Transcription factors (TFs) have been shown to play a key role in the occurrence and development of tumors, including triple-negative breast cancer (TNBC), with a worse prognosis. Machine learning is widely used for establishing prediction models and...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
18 Citations
6,603 Views
14 Pages

The role of the epidermal growth factor receptor (EGFR) in tumor progression and survival is often underplayed. Its expression and/or dysregulation is associated with disease advancement and poor patient outcome as well as drug resistance in breast c...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
3 Citations
1,682 Views
15 Pages

Triple-Clad Fiber Combiner for Holmium-Doped Fiber Lasers Clad-Pumping

  • Nicolas Dalloz,
  • Stefano Bigotta,
  • Thierry Ibach,
  • Christophe Louot and ,
  • Thierry Robin and
  • Anne Hildenbrand-Dhollande
  • + 1 author+ 0 author

The development of a high-power 7 × 1 triple-clad fiber combiner aimed at resonantly clad-pump holmium-doped fiber lasers is presented. Thanks to the implementation in the combiner of a low refractive index glass capillary, we show that the dev...

(This article belongs to the Section Optoelectronics and Optical Materials)
  • Article
  • Open Access
6 Citations
4,661 Views
22 Pages

27 April 2020

Triple negative breast cancer is a collection of heterogeneous breast cancers that are immunohistochemically negative for estrogen receptor, progesterone receptor, and ErbB2 (due to deletion or lack of amplification). No dominant proliferative driver...

  • Article
  • Open Access
10 Citations
3,951 Views
20 Pages

20 August 2022

There are no signaling-based targeted therapies for triple-negative breast cancer. The development of targeted cancer therapy relies on identifying oncogenic signaling drivers, understanding their contributions to oncogenesis and developing inhibitor...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
5 Citations
2,343 Views
23 Pages

Clustering Optimization for Triple-Frequency Combined Observations of BDS-3 Based on Improved PSO-FCM Algorithm

  • Zhaoyong Qian,
  • Yuhua Cao,
  • Xiaoshuang Sun,
  • Lei Ni and ,
  • Zhiyu Wang and
  • Xiaowei Chen
  • + 1 author+ 0 author

3 August 2022

The triple-frequency linear combination method can provide combinations with different characteristics and is one of the important methods to improve the performance of navigation services. Due to the large number of combinations and different combin...

(This article belongs to the Special Issue Pattern Recognition in Remote Sensing)
  • Article
  • Open Access
1 Citations
1,638 Views
18 Pages

21 October 2025

Triple-negative breast cancer (TNBC) is an aggressive, heterogeneous subtype of breast cancer with limited treatment options. Our previous work explored repurposing selinexor, an XPO1 inhibitor, as a novel therapeutic option for TNBC. To enhance its...

(This article belongs to the Special Issue Molecular Advances and Views in Triple-Negative Breast Cancer)
  • Article
  • Open Access
532 Views
25 Pages

14 September 2026

Combined cycle power plants (CCPPs) are the most efficient fossil-fuelled technology available today, yet a significant fraction of the fuel energy still leaves the plant with the heat recovery steam generator (HRSG) exhaust gases at temperatures too...

(This article belongs to the Special Issue New Challenges in Thermodynamics)
  • Article
  • Open Access
4 Citations
1,507 Views
20 Pages

31 October 2025

To date, breast cancer remains one of the leading causes of death among women worldwide. Although various treatments are used in clinical settings, the efficacy and safety of such treatments are limited by tumor biology factors and patient preference...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
14 Citations
5,472 Views
17 Pages

A Heme-Binding Transcription Factor BACH1 Regulates Lactate Catabolism Suggesting a Combined Therapy for Triple-Negative Breast Cancer

  • Joselyn Padilla,
  • Bok-Soon Lee,
  • Karen Zhai,
  • Bethany Rentz and ,
  • Tia Bobo,
  • Norca Maritza Dowling and
  • Jiyoung Lee
  • + 2 authors+ 0 author

31 March 2022

The oncogenic expression or mutation of tumor suppressors drives metabolic alteration, causing cancer cells to utilize diverse nutrients. Lactate is a known substrate for cancer cells, yet the regulatory mechanisms of lactate catabolism are limited....

(This article belongs to the Special Issue New Aspects of Targeting Cancer Metabolism in Therapeutic Approach)
  • Article
  • Open Access
1 Citations
780 Views
27 Pages

Preclinical Pharmacokinetics of a Triple-Combination Intravaginal Ring for HIV Prevention

  • John A. Moss,
  • Priya Srinivasan,
  • Irina Butkyavichene,
  • Manjula Gunawardana and ,
  • Amalia E. Castonguay,
  • John M. Cortez,
  • Patricia Galvan,
  • Sofia Rivera,
  • Jining Zhang and
  • Marc M. Baum
  • + 14 authors+ 9 authors

Background/Objectives: The prevention of sexual HIV-1 acquisition in women and girls in sub-Saharan Africa remains an important public health priority. Expanding the existing biomedical product portfolio to include long-acting vaginal products, such...

(This article belongs to the Special Issue Advancing HIV Prevention and Treatment: Pharmacokinetics, Pharmacodynamics, Toxicokinetics, Formulation and Delivery of Antiretroviral Drugs)
  • Article
  • Open Access
1 Citations
1,189 Views
25 Pages

7 November 2025

Assessing Mine Emergency Rescue Capability (MERC) is critical for ensuring mining safety and advancing sustainable development. However, existing MERC assessments often lack a holistic sustainability perspective. To bridge this gap, this study develo...

(This article belongs to the Special Issue Mineral Resource Utilization and GeoConservation for Sustainable Development)
  • Article
  • Open Access
2,696 Views
15 Pages

9 September 2025

Breast cancer remains the most prevalent cancer among women worldwide and a major contributor to cancer-related mortality. Among its subtypes, triple-negative breast cancer (TNBC) is particularly aggressive, with limited therapeutic options and poor...

(This article belongs to the Section Applied Biosciences and Bioengineering)
  • Review
  • Open Access
11 Citations
4,267 Views
28 Pages

Metformin-Based Combination Approaches for Triple-Negative Breast Cancer

  • Zaid Sirhan,
  • Aya Abu Nada,
  • Nadeen Anabtawi,
  • Anita Thyagarajan and
  • Ravi P. Sahu

Numerous anti-diabetic medications, including metformin, have been explored for their anticancer effects because of the substantial correlation between diabetes and cancer incidence. Metformin has recently gained interest for its anticancer effects a...

(This article belongs to the Special Issue Combination Therapy Approaches for Cancer Treatment)
  • Article
  • Open Access
24 Citations
5,319 Views
15 Pages

Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells

  • Kitti Andreidesz,
  • Balazs Koszegi,
  • Dominika Kovacs,
  • Viola Bagone Vantus and ,
  • Ferenc Gallyas and
  • Krisztina Kovacs
  • + 1 author+ 0 author

19 February 2021

Triple-negative breast cancer (TNBC) has a poor prognosis as the therapy has several limitations, most importantly, treatment resistance. In this study we examined the different responses of triple-negative breast cancer line MDA-MB-231 and hormone r...

(This article belongs to the Special Issue Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches)
  • Review
  • Open Access
113 Citations
15,526 Views
28 Pages

3 January 2023

Due to the absence of hormone receptor (both estrogen receptors and progesterone receptors) along with human epidermal growth factor receptor 2 (HER-2) amplification, the treatment of triple-negative breast cancer (TNBC) cannot benefit from endocrine...

(This article belongs to the Special Issue Immunotherapy of Triple-Negative Breast Cancer)
  • Review
  • Open Access
21 Citations
12,232 Views
20 Pages

7 July 2022

Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we...

  • Case Report
  • Open Access
2 Citations
2,558 Views
7 Pages

Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), is widely used in treating patients with EGFR-mutated non-small-cell lung cancers (NSCLCs), especially in cases with secondary resistance mutatio...

(This article belongs to the Section Thoracic Oncology)
  • Article
  • Open Access
5 Citations
2,381 Views
13 Pages

Triple-Antibiotic Combination Exerts Effective Activity against Mycobacterium avium subsp. hominissuis Biofilm and Airway Infection in an In Vivo Murine Model

  • Elliot M. Offman,
  • Amy Leestemaker-Palmer,
  • Reza Fathi,
  • Bailey Keefe and ,
  • Aida Bibliowicz,
  • Gilead Raday and
  • Luiz E. Bermudez
  • + 2 authors+ 0 author

Objectives: Slow-growing nontuberculous mycobacteria (NTMs) are highly prevalent and routinely cause opportunistic intracellular infectious disease in immunocompromised hosts. Methods: The activity of the triple combination of antibiotics, clarithrom...

  • Article
  • Open Access
23 Citations
4,334 Views
19 Pages

The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells

  • Abrar Softah,
  • Moureq R. Alotaibi,
  • Ali R. Alhoshani,
  • Tareq Saleh and ,
  • Khalid Alhazzani,
  • Mashal M. Almutairi,
  • Raed AlRowis,
  • Samiyah Alshehri,
  • Norah A. Albekairy and
  • Homood M. As Sobeai
  • + 9 authors+ 4 authors

16 November 2023

Despite significant advances in the treatment of triple-negative breast cancer, this disease continues to pose a clinical challenge, with many patients ultimately suffering from relapse. Tumor cells that recover after entering into a state of senesce...

(This article belongs to the Section Molecular Genetics and Genetic Diseases)
  • Article
  • Open Access
27 Citations
4,845 Views
15 Pages

Combination of OX40 Co-Stimulation, Radiotherapy, and PD-1 Inhibition in a Syngeneic Murine Triple-Negative Breast Cancer Model

  • Min Guk Han,
  • Chan Woo Wee,
  • Mi Hyun Kang,
  • Min Ji Kim and ,
  • Seung Hyuck Jeon and
  • In Ah Kim
  • + 1 author+ 0 author

29 May 2022

Immune checkpoint inhibitors have been successful in a wide range of tumor types but still have limited efficacy in immunologically cold tumors, such as breast cancers. We hypothesized that the combination of agonistic anti-OX40 (α-OX40) co-sti...

(This article belongs to the Topic Anti-Tumor Immune Responses)
  • Article
  • Open Access
6 Citations
2,573 Views
37 Pages

Triple Combination of Entinostat, a Bromodomain Inhibitor, and Cisplatin Is a Promising Treatment Option for Bladder Cancer

  • Lukas M. Bollmann,
  • Friedrich Lange,
  • Alexandra Hamacher,
  • Lukas Biermann and ,
  • Linda Schäker-Hübner,
  • Finn K. Hansen and
  • Matthias U. Kassack
  • + 2 authors+ 0 author

2 October 2024

Background/Objectives. Cisplatin is part of the first-line treatment of advanced urothelial carcinoma. Cisplatin resistance is a major problem but may be overcome by combination treatments such as targeting epigenetic aberrances. Here, we investigate...

(This article belongs to the Special Issue New Advances in Urothelial Cancer: Diagnosis, Therapy and Prognosis)
  • Article
  • Open Access
136 Views
32 Pages

Antidepressant-like Activity of a Triple Combination of Venlafaxine, Codeine and Nor-Binaltorphimine in the Mouse Tail Suspension Test

  • Cristina Lungu,
  • Călin Muntean,
  • Horia Păunescu,
  • Ruxandra-Cristina Marin and ,
  • Florin-Adrian Lungu,
  • Mihnea Costescu,
  • Cristina Isabel Viorica Ghiță,
  • Ion Fulga and
  • Oana Andreia Coman
  • + 4 authors+ 0 author

29 October 2026

About one-third of patients with major depressive disorder do not remit on conventional monoaminergic antidepressants. Venlafaxine (VEN) is a classic antidepressant that inhibits serotonin and norepinephrine reuptake. Venlafaxine does not bind opioid...

(This article belongs to the Special Issue Molecular Insights into Anxiety and Depression: Pathomechanisms and Therapeutic Strategies)
  • Article
  • Open Access
30 Citations
4,441 Views
13 Pages

Antiproliferative Mechanisms of a Polyphenolic Combination of Kaempferol and Fisetin in Triple-Negative Breast Cancer Cells

  • Mohd. Afzal,
  • Abdullah Alarifi,
  • Abdalnaser Mahmoud Karami,
  • Rashid Ayub and ,
  • Naaser A. Y. Abduh,
  • Waseem Sharaf Saeed and
  • Mohd. Muddassir
  • + 2 authors+ 0 author

Herein, we investigate the combinatorial therapeutic effects of naturally occurring flavonoids kaempferol (K) and fisetin (F) on triple-negative breast cancer (TNBC: MDA-MB-231 cell line). Dose-dependent MTT assay results show that K and F exhibited...

(This article belongs to the Special Issue Prevention and Drug Treatment of Breast Cancer)
  • Review
  • Open Access
27 Citations
6,447 Views
22 Pages

25 May 2024

Triple-negative breast cancer (TNBC), lacking specific receptors found in other breast cancer subtypes, poses significant treatment challenges due to limited therapeutic options. Therefore, it is necessary to develop novel treatment approaches for TN...

(This article belongs to the Special Issue Pathology and Treatment of Triple-Negative Breast Cancer)
  • Abstract
  • Open Access
1,315 Views
1 Page

Breast cancer is a worldwide health problem as one of the most prevalent types of tumors in the female population. Despite the availability of many therapies, including doxorubicin, novel chemotherapeutic approaches are being studied for this disease...

(This article belongs to the Proceedings of The 8th International Electronic Conference on Medicinal Chemistry)
  • Article
  • Open Access
12 Citations
4,667 Views
8 Pages

Less time-consuming, easy-to-apply and more reliable cognitive screening tests are essential for use in primary care. The aim of this study was to investigate the diagnostic value of the Turkish version of the Rapid Cognitive Screen (RCS-T) and Tripl...

(This article belongs to the Special Issue Diagnosis of Dementia and Cognitive Impairment)
  • Article
  • Open Access
15 Citations
4,023 Views
24 Pages

Sequential Delivery of Novel Triple Drug Combination via Crosslinked Alginate/Lactoferrin Nanohybrids for Enhanced Breast Cancer Treatment

  • Mai Salah,
  • Marwa A. Sallam,
  • Mona A. Abdelmoneem,
  • Mohamed Teleb and ,
  • Kadria A. Elkhodairy,
  • Adnan A. Bekhit,
  • Asmaa F. Khafaga,
  • Ahmed E. Noreldin,
  • Ahmed O. Elzoghby and
  • Sherine N. Khattab
  • + 5 authors+ 0 author

While breast cancer remains a global health concern, the elaboration of rationally designed drug combinations coupled with advanced biocompatible delivery systems offers new promising treatment venues. Herein, we repurposed rosuvastatin (RST) based o...

(This article belongs to the Special Issue Lactoferrin in Biomedical Applications)
  • Article
  • Open Access
25 Citations
7,746 Views
17 Pages

Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies

  • Saifun Nahar,
  • Yue Huang,
  • Bethany A. Nagy,
  • John A. Zebala and ,
  • Dean Y. Maeda,
  • Udo Rudloff,
  • Joost J. Oppenheim and
  • De Yang
  • + 3 authors+ 0 author

19 April 2023

Triple-negative breast carcinoma (TNBC) is one of the most aggressive types of solid-organ cancers. While immune checkpoint blockade (ICB) therapy has significantly improved outcomes in certain types of solid-organ cancers, patients with immunologica...

(This article belongs to the Special Issue The Development of Effective Therapy Targeting the Microenvironment of Cancer)
  • Article
  • Open Access
21 Citations
4,013 Views
14 Pages

Safety and Survival Outcomes of Liver Resection following Triple Combination Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma

  • Yin Long,
  • Jue Huang,
  • Jianguo Liao,
  • Dongbo Zhang and ,
  • Ziqi Huang,
  • Xiaodong He and
  • Lei Zhang
  • + 2 authors+ 0 author

17 December 2023

Triple combination conversion therapy, involving transcatheter arterial chemoembolization (TACE) or hepatic arterial infusion chemotherapy (HAIC) combined with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs), has shown an en...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
32 Citations
4,607 Views
16 Pages

Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer

  • Jeremy Johnson,
  • Zeta Chow,
  • Dana Napier,
  • Eun Lee and ,
  • Heidi L. Weiss,
  • B. Mark Evers and
  • Piotr Rychahou
  • + 2 authors+ 0 author

19 May 2020

Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype and is characterized by poor survival. Radiotherapy plays an important role in treating TNBC. The purpose of this study was to determine whether inhibiting the AMP-acti...

(This article belongs to the Section Cell Signaling)
  • Interesting Images
  • Open Access
409 Views
4 Pages

Sinonasal and Pulmonary Computed Tomography Images Before and After Triple-Combination Therapy in a Patient with Cystic Fibrosis Without ΔF508 Mutations

  • Corrado Tagliati,
  • Giovanna Campagna,
  • Maria Di Sabatino,
  • Giuseppe Lanni and ,
  • Davide Battista and
  • Pietro Ripani
  • + 1 author+ 0 author

Here, we present the case of a 25-year-old patient with G542X and G85E cystic fibrosis mutations who underwent computed tomography examination before and after triple-combination therapy. Clear improvement in sinonasal and lung involvement is visible...

(This article belongs to the Collection Interesting Images)
  • Article
  • Open Access
17 Citations
6,382 Views
15 Pages

Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy

  • Archana P. Thankamony,
  • Reshma Murali,
  • Nitheesh Karthikeyan,
  • Binitha Anu Varghese and ,
  • Wee S. Teo,
  • Andrea McFarland,
  • Daniel L. Roden,
  • Holly Holliday,
  • Christina Valbirk Konrad and
  • Radhika Nair
  • + 13 authors+ 8 authors

8 September 2020

The basic helix-loop-helix (bHLH) transcription factors inhibitor of differentiation 1 (Id1) and inhibitor of differentiation 3 (Id3) (referred to as Id) have an important role in maintaining the cancer stem cell (CSC) phenotype in the triple-negativ...

(This article belongs to the Special Issue Biomolecules and Cancer Prevention)
  • Article
  • Open Access
29 Citations
5,163 Views
14 Pages

Characterization of GNSS Signals Tracked by the iGMAS Network Considering Recent BDS-3 Satellites

  • Xin Xie,
  • Rongxin Fang,
  • Tao Geng,
  • Guangxing Wang and ,
  • Qile Zhao and
  • Jingnan Liu
  • + 1 author+ 0 author

3 November 2018

The international GNSS monitoring and assessment system (iGMAS) tracking network has been established by China to track multi-GNSS satellites. A key feature of iGMAS stations is the capability to fully track new navigation signals from the recently d...

(This article belongs to the Special Issue Environmental Research with Global Navigation Satellite System (GNSS))
  • Review
  • Open Access
105 Citations
22,384 Views
42 Pages

Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis

  • Mafalda Bacalhau,
  • Mariana Camargo,
  • Grace A. V. Magalhães-Ghiotto,
  • Sybelle Drumond and ,
  • Carlos Henrique M. Castelletti and
  • Miquéias Lopes-Pacheco
  • + 1 author+ 0 author

Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive multisystemic pathology. Over the last decade, the introduction of CF transmembrane conductance regulator (CFTR) modulator drugs into clinical practice has profou...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
17 Citations
4,617 Views
20 Pages

Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models

  • Maryam Nakhjavani,
  • Eric Smith,
  • Helen M. Palethorpe,
  • Yoko Tomita and ,
  • Kenny Yeo,
  • Tim J. Price,
  • Amanda R. Townsend and
  • Jennifer E. Hardingham
  • + 3 authors+ 0 author

Key problems of chemotherapies, as the mainstay of treatment for triple-negative breast cancer (TNBC), are toxicity and development of tumour resistance. Using response surface methodology, we previously optimised the combination of epimers of ginsen...

(This article belongs to the Special Issue Potential Molecular Targets and Therapeutics in Triple-Negative Breast Cancer)
  • Article
  • Open Access
12 Citations
4,128 Views
13 Pages

Molecular Imaging of Oxygenation Changes during Immunotherapy in Combination with Paclitaxel in Triple Negative Breast Cancer

  • Tiara S. Napier,
  • Shannon E. Lynch,
  • Yun Lu,
  • Patrick N. Song and ,
  • Andrew C. Burns and
  • Anna G. Sorace
  • + 1 author+ 0 author

Hypoxia is a common feature of the tumor microenvironment, including that of triple-negative breast cancer (TNBC), an aggressive breast cancer subtype with a high five-year mortality rate. Using [18F]-fluoromisonidazole (FMISO) positron emission tomo...

(This article belongs to the Special Issue Tumor Microenvironment and Cancer Therapy)
  • Article
  • Open Access
37 Citations
6,716 Views
25 Pages

10 March 2021

There is an unmet medical need for the development of new targeted therapeutic strategies for triple-negative breast cancer (TNBC). With drug combination screenings, we found that the triple combination of the protein kinase inhibitors (PKIs) of the...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
1 Citations
1,616 Views
13 Pages

Alterations in PD-L1+ Myeloid Cells and Immune Infiltration Are Associated with Atezolizumab and Paclitaxel Therapy Success in a Triple-Negative Breast Cancer Model

  • Kerim Bora Yilmaz,
  • Ece Tavukcuoglu,
  • Hamdullah Yanik,
  • Pelin Seçken and ,
  • Ertugrul Celik,
  • Sumeyra Guler,
  • Mehmet Mert Hidiroglu,
  • Ibrahim Burak Bahcecioglu,
  • Ismail Erturk and
  • Gunes Esendagli
  • + 7 authors+ 2 authors

22 March 2026

Background and Objectives: A combination of chemotherapy and immunotherapy may improve cancer treatment outcomes; however, determining which patient groups will benefit from immunotherapy is critical. Triple-negative breast cancer (TNBC) achieves lim...

(This article belongs to the Special Issue Future Trends in Breast Cancer Management)
  • Article
  • Open Access
4 Citations
2,922 Views
21 Pages

15 May 2020

The cycle slip detection (CSD) and cycle slip repair (CSR) are easily affected by ionospheric delay and observational noise. Aiming at mitigating the above disadvantage, a new BeiDou navigation satellite system (BDS) triple-frequency CSR method (BTCS...

(This article belongs to the Special Issue Recent Advances in GNSS-based High Precision Positioning Technology: Part I)
  • Article
  • Open Access
32 Citations
7,731 Views
17 Pages

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines

  • Aleksandra Simiczyjew,
  • Ewelina Dratkiewicz,
  • Marleen Van Troys,
  • Christophe Ampe and ,
  • Ilona Styczeń and
  • Dorota Nowak
  • + 1 author+ 0 author

17 September 2018

Triple-negative breast cancer (TNBC) is the most challenging subtype to treat due to the lack of estrogen receptor, progesterone receptor, and HER2 expression, which excludes the usage of directed targeted therapy against them. Promising therapeutic...

(This article belongs to the Special Issue Tyrosine Kinase Signaling Pathways in Cancer)
  • Article
  • Open Access
18 Citations
4,383 Views
13 Pages

We evaluated the utility of optical redox imaging (ORI) to identify the therapeutic response of triple-negative breast cancers (TNBC) under various drug treatments. Cultured HCC1806 and MDA-MB-231 cells treated with FK866 (nicotinamide phosphoribosyl...

(This article belongs to the Special Issue New Drugs for Breast Cancer Treatment)

of 42